Roderick Gillum - Kellanova Independent Director
| K Stock | USD 56.54 0.47 0.84% |
Director
Mr. Roderick D. Gillum is Independent Director of the Company. He has served as a Kellogg Director since February 2019. He has served as a member of the Board of Trustees of the W.K. Kellogg Foundation since January 2007. He also served as board chair in 20122013 and cotrustee of the W.K. Kellogg Foundation Trust from March 2017 to February 2019 since 2019.
| Age | 70 |
| Tenure | 5 years |
| Address | 412 North Wells Street, Chicago, IL, United States, 60654 |
| Phone | 269 961 2000 |
| Web | https://www.kellanova.com |
Kellanova Management Efficiency
The company has return on total asset of 0.0513 % which means that for every 100 dollars spent on assets, it generated a profit of $0.0513. This is way below average. Similarly, it shows a return on equity (ROE) of 0.2035 %, implying that it made 0.2035 on every $100 invested by shareholders. Kellanova's management efficiency ratios could be used to measure how well Kellanova manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is expected to rise to 0.15 this year. Return On Capital Employed is expected to rise to 0.29 this year. Change To Liabilities is expected to rise to about 496.3 M this year, although the value of Total Current Liabilities will most likely fall to about 3.2 B.Similar Executives
| Showing other executives | DIRECTOR Age | ||
| Michael Edwards | Central Garden Pet | 57 | |
| Michael Griffith | Central Garden Pet | N/A | |
| M Springer | Central Garden Pet | 50 | |
| Mary Springer | Central Garden Pet | 60 | |
| Alfred Piergallini | Central Garden Pet | 69 | |
| John Hanson | Central Garden Pet | 58 | |
| Andrew Woeber | Central Garden Pet | 49 | |
| John Hanson | Central Garden Pet | 58 | |
| Michael Griffith | Central Garden Pet | N/A | |
| Lisa Burquest | The A2 Milk | N/A | |
| Jesse Wu | The A2 Milk | 61 | |
| John Balousek | Central Garden Pet | 72 | |
| Thomas Colligan | Central Garden Pet | 73 | |
| George Roeth | Central Garden Pet | 56 | |
| Michael Edwards | Central Garden Pet | 57 | |
| Christopher Metz | Central Garden Pet | 51 | |
| Philippa Greenwood | The A2 Milk | N/A | |
| David Chichester | Central Garden Pet | 69 | |
| Brooks Pennington | Central Garden Pet | 63 | |
| Andrew Woeber | Central Garden Pet | 49 | |
| M Springer | Central Garden Pet | 50 | |
Management Performance
| Return On Equity | 0.2 | ||||
| Return On Asset | 0.0513 |
Kellanova Leadership Team
Elected by the shareholders, the Kellanova's board of directors comprises two types of representatives: Kellanova inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Kellanova. The board's role is to monitor Kellanova's management team and ensure that shareholders' interests are well served. Kellanova's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Kellanova's outside directors are responsible for providing unbiased perspectives on the board's policies.
| CFA IV, Vice Planning | ||
| Paul Norman, Sr. VP and President of North America | ||
| Charisse Hughes, Senior Officer | ||
| Gary Pilnick, Vice Chairman - Corporate Development and Chief Legal Officer | ||
| Donald Mondano, Principal Accounting Officer, Vice President Corporate Controller | ||
| Marcella Kain, Senior Director | ||
| Mary Laschinger, Independent Director | ||
| Lesley Salmon, Senior Officer | ||
| Donald Knauss, Lead Independent Director | ||
| Christopher Hood, Senior Vice President, President of Kellogg North America | ||
| Nicolas Amaya, Senior Vice President and Presidentident, Kellogg Latin America | ||
| Victor Cade, Senior America | ||
| Doug Vandevelde, Senior Category | ||
| Erica Mann, Independent Director | ||
| Peter Rahal, President RX | ||
| Fareed Khan, CFO | ||
| Noel Wallace, Director | ||
| Roderick Gillum, Independent Director | ||
| Kurt Forche, Vice President Corporate Controller | ||
| Maria Mejia, Senior Vice President and Presidentident, Kellogg Latin America | ||
| Alistair Hirst, Senior Vice President - Global Supply Chain | ||
| Richard Dreiling, Independent Director | ||
| Ann Korologos, Independent Director | ||
| John Bryant, Chairman, CEO and Chairman of Executive Committee | ||
| John Min, Senior Secretary | ||
| J Schlotman, Independent Director | ||
| Joel Kooi, VP Treasurer | ||
| Lauren Beck, Senior Relations | ||
| Carter Cast, Independent Director | ||
| Clive Sirkin, Senior Vice President Chief Growth Officer | ||
| Melissa Howell, Senior Vice President - Global Human Services of the company | ||
| Gordon Gund, Lead Independent Director | ||
| Steven Cahillane, Chairman of the Board, President, Chief Executive Officer | ||
| Rebecca Boustead, Director Pacific | ||
| John Dillon, Independent Director | ||
| Shumit Kapoor, Senior Vice President and Presidentident - Kellogg Asia Pacific, Middle East and Africa | ||
| James Jenness, Non-Executive Director | ||
| Stephanie Burns, Independent Director | ||
| La Tabron, Independent Director | ||
| Ronald Dissinger, CFO and Sr. VP | ||
| David Lawlor, Senior Vice President, President, Kellogg Europe | ||
| Zachary Gund, Independent Director | ||
| G Gund, Independent Director | ||
| Amit Banati, Senior Vice President and Presidentident, Asia Pacific | ||
| Michael Hunter, VP Sales | ||
| Rogelio Rebolledo, Independent Director | ||
| Cynthia Milligan, Independent Director | ||
| Carolyn Tastad, Independent Director | ||
| Monica McGurk, Senior Vice President Chief Growth Officer | ||
| Kris Bahner, Senior Officer | ||
| Rodrigo Lance, Senior Vice President - Global Supply Chain | ||
| Samantha Long, Senior Vice President - Global Human Resources |
Kellanova Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Kellanova a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.2 | ||||
| Return On Asset | 0.0513 | ||||
| Profit Margin | 0.07 % | ||||
| Operating Margin | 0.13 % | ||||
| Current Valuation | 25.35 B | ||||
| Shares Outstanding | 341.76 M | ||||
| Shares Owned By Insiders | 0.94 % | ||||
| Shares Owned By Institutions | 87.40 % | ||||
| Number Of Shares Shorted | 13.09 M | ||||
| Price To Earning | 16.74 X |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Kellanova. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in industry. For more information on how to buy Kellanova Stock please use our How to buy in Kellanova Stock guide.You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.
Complementary Tools for Kellanova Stock analysis
When running Kellanova's price analysis, check to measure Kellanova's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Kellanova is operating at the current time. Most of Kellanova's value examination focuses on studying past and present price action to predict the probability of Kellanova's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Kellanova's price. Additionally, you may evaluate how the addition of Kellanova to your portfolios can decrease your overall portfolio volatility.
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk |
Is Kellanova's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Kellanova. If investors know Kellanova will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Kellanova listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.13) | Dividend Share 2.34 | Earnings Share 2.25 | Revenue Per Share 38.359 | Quarterly Revenue Growth (0.17) |
The market value of Kellanova is measured differently than its book value, which is the value of Kellanova that is recorded on the company's balance sheet. Investors also form their own opinion of Kellanova's value that differs from its market value or its book value, called intrinsic value, which is Kellanova's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Kellanova's market value can be influenced by many factors that don't directly affect Kellanova's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Kellanova's value and its price as these two are different measures arrived at by different means. Investors typically determine if Kellanova is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Kellanova's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.